Table: Brightpath Biotherapeutics -2023/24 parent forecast

BrightPath Biotherapeutics Co

26/01/2024 07:40

Jan 26 (Reuters) -
              Brightpath Biotherapeutics Co., Ltd.     
              PARENT- ONLY EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2024      Mar 31, 2024   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales            0 mln             0 mln      
  Operating      loss 1.59         loss 1.35    
  Recurring      loss 1.59         loss 1.35    
  Net            loss 1.59         loss 1.36    
  EPS         loss 24.04 yen    loss 21.58 yen  
 
  NOTE - Brightpath Biotherapeutics Co., Ltd..    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T